GEN

SEC Filing Summary: Symantec Corporation (10-K)

Business Context and Reporting Period

Company: Symantec Corporation (Note: Request metadata listed "Gen Digital Inc.", but the filing text identifies the registrant as Symantec Corporation).

Reporting Period: Fiscal year ended March 29, 2002 (52 weeks).

Business Overview: Symantec provides content and network security software and appliance solutions to enterprises, individuals, and service providers. The company operates in five segments: Enterprise Security, Enterprise Administration, Consumer Products, Services, and Other. Key products include antivirus, firewall, VPN, intrusion detection, and vulnerability management solutions.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 26% to $1.07 billion, driven by a full year of sales from the AXENT acquisition (Enterprise Security) and strong growth in Consumer Products (Norton AntiVirus and Internet Security).
• Profitability Decline: Despite revenue growth, the company reported a net loss of $28.2 million compared to a net income of $63.9 million in the prior year. This was primarily due to a 176% increase in goodwill amortization ($196.8 million) related to the AXENT acquisition.
• Segment Performance: Enterprise Security revenue grew 61% to $454.9 million. Consumer Products revenue grew 14% to $376.1 million. Enterprise Administration revenue declined 4% due to lower pcAnywhere sales.
• Debt Issuance: In October 2001, the company issued $600 million in 3% convertible subordinated debentures, increasing interest expense to $9.2 million.
• Restructuring: Incurred $20.4 million in restructuring and site closure expenses, primarily for consolidating facilities in the U.S. and Europe.

Guidance, Outlook, and Risks

• Accounting Changes: Effective April 1, 2002, the company will adopt SFAS No. 142, which eliminates goodwill amortization. Management expects this to increase fiscal 2003 operating results by approximately $198.4 million, though results will be subject to annual impairment testing.
• Consumer Market Outlook: Management noted that the high growth rate in consumer antivirus sales during the second half of fiscal 2002 (spurred by virus outbreaks and post-9/11 security concerns) may not be sustainable.
• Key Risks:
  • Competition: Intense price competition and potential inclusion of security features in operating systems (e.g., Microsoft Windows) could reduce demand.
  • Seasonality: Sales are heavily weighted toward the December and March quarters.
  • Acquisition Integration: Risks associated with integrating acquired businesses (AXENT, Lindner & Pelc, Foster-Melliar) and potential goodwill impairment.
  • Legal Proceedings: Ongoing patent infringement lawsuits (e.g., Altiris, PowerQuest, Hilgraeve) and a Canadian copyright judgment (Triolet Systems) involving accrued costs.

Investor Verification Checklist

• Goodwill Amortization Impact: Verify the magnitude of the $196.8 million goodwill amortization charge and confirm the projected $198.4 million benefit from SFAS 142 adoption in fiscal 2003.
• Consumer Sales Sustainability: Assess whether the 14% growth in Consumer Products can be maintained without the temporary boost from specific virus outbreaks.
• Debt Covenants: Review the financial covenants associated with the $600 million convertible debentures and synthetic lease arrangements (requiring minimum cash balances and EBITDA ratios).
• Legal Accruals: Confirm the adequacy of the $12.5 million legal expense accrual as of March 31, 2002, regarding pending litigation.
• Channel Inventory: Evaluate the company's estimates for channel revenue deferrals and product return reserves, which are critical accounting policies affecting revenue recognition.